Penalty exposure cap
₹250 cr
Section 8(5) security failure caps at ₹250 cr; a paediatric data breach stacks Section 9 (₹200 cr) plus POCSO criminal liability. Add MCI / NDPS retention non-compliance and you are running a three-front response.
Industry guide · #2 most exposed · Critical risk
National diagnostic labs, pathology chains, radiology networks, home-collection platforms and aggregator marketplaces (think OncQuest, Dr Lal PathLabs, Metropolis, Thyrocare, SRL, Agilus, Redcliffe) sit at the intersection of health data, financial data, Aadhaar-linked KYC and insurance claim flows. A single LIS / HIS / mobile-app misconfiguration here cascades into Section 8 (₹250 cr), Section 9 (₹200 cr for paediatric / POCSO records), MCI Regulations 2002, NDPS Act 1985 and ABDM all at once.
Penalty exposure cap
₹250 cr
Section 8(5) security failure caps at ₹250 cr; a paediatric data breach stacks Section 9 (₹200 cr) plus POCSO criminal liability. Add MCI / NDPS retention non-compliance and you are running a three-front response.
Realistic effort
180–440 hrs (10–22 weeks calendar)
India-resident DPO + Medical Records Officer + InfoSec + Legal + IT (LIS/HIS owner)
Annual budget
₹10–40 lakh / yr for tooling, DPO, independent audit & DPIA
Tooling + DPO retainer + audit
Sector regulators
MoH&FW · MCI / NMC · CDSCO · IRDAI (claims) · NHA / ABDM · CERT-In
Stack on top of DPDP — comply with both
Why this industry
Diagnostic chains process the highest-volume + highest-sensitivity overlap in Indian healthcare — lab reports, imaging, prescriptions, billing, Aadhaar, insurance and corporate-wellness PII flow through the same LIS/HIS stack. Statutory retention obligations (MCI 3 years, NDPS 2 years, POCSO 23(2) restrictions) directly conflict with the DPDP Section 8(7) erasure obligation, and MeitY has signalled diagnostics as a leading SDF candidate.
What you must do
Section 5 + Section 6
One bundled "I agree" at registration does not cover research, anonymised studies or partner sharing. Each purpose needs its own captured consent under Section 6 with a withdraw path under Section 6(4).
Section 9 + POCSO
Under-18 sample collection (paediatric oncology, school screenings) triggers verifiable parental consent. POCSO Section 23(2) adds a disclosure ban for offence victims — heightened protection beyond Section 9.
Section 8(7) + MCI Reg 1.3.2 + NDPS
MCI Regulations 2002 require 3-year minimum retention from last visit; NDPS Act 1985 needs 2 years for Schedule H/X prescriptions. DPDP erasure cannot override these — refusal must cite the specific regulation.
Section 16 + ABDM Policy
Once you integrate with Ayushman Bharat Digital Mission, ABDM mandates India residency for health records — DPDP is silent, ABDM is not.
Rule 7(1)-(2)
Phase-1 notification "without delay" to DPB, Phase-2 detailed report within 72 hours covering Rule 7(2)(a)-(e). Stacks on top of the CERT-In 6-hour window for any cyber incident.
Section 10 + Rule 13
India-resident DPO reporting directly to the Board; independent annual audit; DPIA within 12 months of designation. National chains processing tens of millions of patients should plan as if designated.
Rule 8(3) + Seventh Schedule
Diagnostic labs and every downstream processor (cloud, telecom, billing, courier) must retain processing and traffic logs for at least 12 months — flow down via the DPA.
What to ship
Effort estimates assume an in-house engineer + an external CMP/DPO partner where indicated. Cumulative time gets you to a defensible posture; full SDF maturity adds 1–2 quarters on top.
Purpose register mapping every LIS / HIS / mobile-app processing activity to Section 4 lawful basis
2–3 weeks · Prerequisites checklist →
Itemised privacy notice covering testing + research + ABDM + marketing
1 week · Notice template →
Granular consent UI for patient registration (OPD + home-collection + telemedicine)
2–3 weeks engineering · Banner builder →
Age-gate + verifiable parental consent for paediatric samples
2–4 weeks engineering + DigiLocker / payment handshake
Retention schedule per record type (lab / imaging / billing / consent) with MCI + NDPS overrides
1–2 weeks clinical + legal
Vendor inventory + DPAs for every processor (cloud, courier, billing, KYC, ABDM gateway)
3–4 weeks legal + ops
Section 8 security baseline — AES-256 at rest, TLS 1.2+ in transit, RBAC, MFA, SIEM
4–8 weeks engineering
Two-phase breach playbook — DPB Phase-1 + 72-hour Phase-2 + CERT-In 6-hour + ABDM notification
2 weeks · Breach template →
Independent DPIA + annual audit (if SDF likely)
6–10 weeks empanelled auditor · SDF guide →
Gap analysis across the 10 DPDP categories (lawful basis, security, children, SDF, rights, cross-border, governance, vendor, breach, sector-specific)
4–6 weeks · Gap analysis →
What goes wrong
Section 8(5) ₹250 cr cap + Section 9 if minors affected + CERT-In + ABDM + MCI / NMC scrutiny. Realistic exposure crosses ₹100 cr.
MCI Reg 1.3.2 mandates 3-year retention from last visit. Refusal must cite the regulation and explain the override in writing within 90 days.
Section 9 + POCSO disclosure breach + Section 8(5). Notify DPB Phase-1 immediately, file Phase-2 within 72 hours, notify guardians, escalate to head of clinical operations.
NDPS Act non-compliance — separate offence from DPDP. Restore from backup, re-apply NDPS 2-year override, update retention configuration.
Close these first
Open the 62-item prerequisites checklist and complete the Data Inventory category first — it unlocks every other category.
Open the fix →Build the override register before any DPDP erasure SOP is written. Document the specific regulation per record category.
Open the fix →Replace with DigiLocker / payment / OTP handshake — Section 9 is the second-highest penalty band after Section 8.
Open the fix →Single incident commander, three notifications (DPB Phase-1, CERT-In, ABDM) — drill annually.
Open the fix →Diagnostics / Pathology · FAQ
Mandatory only if designated SDF, but any national chain processing more than a few million patients should plan as if designated. The DPO must be an individual (not outsourced to a firm) and must report directly to the Board under Rule 13.
MCI Regulations 2002 mandate a 3-year minimum retention of patient records from last visit; NDPS Act 1985 mandates 2 years for Schedule H/X prescriptions. DPDP Section 8(7) allows retention where another law mandates it — the refusal of an erasure request must cite the specific regulation in writing.
No. ABDM has its own consent artefact for each share event, but DPDP Section 5 still requires the itemised notice (purposes, categories, rights, grievance officer) and Section 6 still requires withdrawal as easy as giving consent. Align both — do not collapse them.
AES-256 at rest, TLS 1.2+ in transit, RBAC + MFA for privileged access, SIEM-grade monitoring with anomaly alerts, 12-month processing log retention, annual VAPT, and a two-phase breach playbook covering DPB + CERT-In + ABDM. Most ISO 27001 / ISO 27799 certified labs are already 70 % of the way there.
POCSO Section 23(2) prohibits disclosure of a child victim's identity — this is a criminal-law restriction that runs alongside DPDP Section 9. Even with valid parental consent under DPDP, POCSO disclosure restrictions still apply for offence-related records.
Compare across sectors
Highest DPDP exposure of any Indian sector — payment data, KYC, credit profiles all in scope.
Health data is the highest-sensitivity category — DPDP overlaps with ABDM and the Clinical Establishments rules.
Children's data is the headline restriction — verifiable parental consent, no tracking, no targeted ads.